MANNATECH INC Effective Income Tax Rate Reconciliation, Tax Contingency, Percent
MANNATECH INC (MTEX) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Percent of 0.00% for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-15.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies · last filed 2022-03-15
- MANNATECH INC effective income tax rate reconciliation, tax contingency, percent for fiscal 2021 was 0.00%.
- MANNATECH INC effective income tax rate reconciliation, tax contingency, percent for fiscal 2020 was -25.30%.
- MANNATECH INC effective income tax rate reconciliation, tax contingency, percent for fiscal 2019 was 0.00%.
- MANNATECH INC effective income tax rate reconciliation, tax contingency, percent for fiscal 2018 was -0.50%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent 12 month |
|---|---|
| 2021-12-31 | 0.00% 10-K · filed 2022-03-15 |
| 2020-12-31 | -25.30% 10-K · filed 2022-03-15 |
| 2019-12-31 | 0.00% 10-K · filed 2021-03-19 |
| 2018-12-31 | -0.50% 10-K · filed 2020-03-26 |
| 2017-12-31 | -22.60% 10-K · filed 2019-03-11 |
| 2016-12-31 | 12.80% 10-K · filed 2018-03-26 |
| 2015-12-31 | -0.20% 10-K · filed 2017-03-14 |
| 2014-12-31 | 0.50% 10-K · filed 2016-03-15 |
| 2013-12-31 | -17.00% 10-K · filed 2015-03-10 |
| 2012-12-31 | 315.20% 10-K · filed 2014-03-18 |
| 2011-12-31 | -10.50% 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |